James M. Whitehurst has been appointed Interim Chief Executive Officer, President and a member of the Board. Mr. Riccitiello will continue to advise Unity to ensure a smooth transition. "It’ s ...

Unity Announces Leadership Transition James M. Whitehurst Appointed Interim Chief Executive Officer and President Company Reaffirms Third Quarter 2023 Guidance ...

UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that ...